National Health Investors FFO of $1.12 misses by $0.02, revenue of $113.48M beats by $1.32M (NHI:NYSE)
National Health Investors reported Q3 FFO of $1.12, missing estimates by $0.02, but revenue of $113.48M beat expectations by $1.32M. The company also provided 2026 guidance for net income, ranging from $687.0M to $687.6M.
How this was made
The 30-second read
Why it matters
The earnings numbers provide fresh data for valuation models; the FFO miss may trigger a slight sell‑off, while the revenue beat could attract value‑oriented buyers.
Market read
Primary earnings disclosure for a mid‑cap REIT; relevant for investors tracking health‑care real estate performance.
What to watch
Management commentary on future growth and cost control was not detailed in the release.
Background
National Health Investors released its Q3 earnings via a press release, highlighting a small FFO miss and a modest revenue beat.
Ticker impact
Q3 FFO of $1.12 missed expectations by $0.02 and revenue of $113.48M beat estimates by $1.32M.
likely modest downside as the market prices in the FFO miss
Investors focus on core profitability; a $0.02 miss on FFO is a negative signal, while revenue beat offers limited upside.
Market effects
REIT sector may see slight pressure from the earnings miss.
U.S. market impact limited to health‑care REIT niche.
Minimal global effect; primarily a domestic REIT story.
Counterpoint
The revenue beat could outweigh the FFO miss, supporting a short‑term rally.
Key entities
- companyNational Health Investors, Inc.
U.S. listed REIT focused on health‑care properties.
